Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwide installed base increased by 23 placements in the fourth quarter HORSHAM, Pa. , Jan.
STRATA Skin Sciences Announces the Introduction of “Home by XTRAC™”
HORSHAM, Pa. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the
STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference
HORSHAM, Pa. , Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic